Supply Issues Becton Dickinson Skin Disinfectant Products (ICN 3397)

• The supply issue with skin disinfectants from Becton Dickinson and Gama Healthcare is continuing.
• Three product codes remain subject to Protect Demand Management:
  • MRB303, DMD85006 and MRB306.
• One further product code is now subject to Protect Demand Management:
  • DMK004.
• Two affected product codes remain suspended and unavailable to order:
  • DMD85004 and DMK000.
• Six product codes are now affected in total.
• Products subject to demand management are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• MRB303 is currently being demand managed. Once the remaining stock has been depleted, orders will be fulfilled using DMD85006, the US version of the product, as a direct alternative until MRB303 stock becomes available again.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 31 October 2026.

• The supply issue with Chloraprep products from Becton Dickinson UK Ltd is continuing.
• Three affected product codes remain subject to Protect Demand Management:
  • DMD85006 – 1.5ml sterile applicator 2% chlorhexidine in 70% IPA clear
  • MRB303 – Skin Disinfectant Medicinal Product 1.5ml sterile applicator 2% chlorhexidine gluconate in 70% IPA clear solution
  • MRB306 – Skin Disinfectant Medicinal Product 3ml sterile applicator 2% chlorhexidine gluconate in 70% IPA clear solution.
• Two product codes remain suspended and unavailable to order:
  • DMD85004 – 1.75ml swab stick 2% chlorhexidine in 70% IPA sterile solution
  • DMK000 – Skin Disinfectant Medicinal Product – 1ml sterile applicator 2% chlorhexidine gluconate in 70% IPA clear solution.
• Five product codes remain affected in total.
• Please note that DMD85007 is currently being managed separately under the supplier’s demand management process.
• Products subject to demand management are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 31 October 2026.

• The supply issue with Chloraprep products from Becton Dickinson UK Ltd is continuing.
• We can confirm that Becton Dickinson UK Ltd has had derogation approval for two products from Medicines and Healthcare products Regulatory Agency (MHRA) to supply US licenced Chloraprep 1.75ml swab stick and Chloraprep Clear 1.5ml Frepp applicator to the UK market.
• The two products are currently being brought into stock and will be supplied under new National Product Codes (NCP):
  • DMD85006 – 1.5ml sterile applicator 2% chlorhexidine in 70% IPA clear
  • DMD85007 – 1.75ml swab stick 2% chlorhexidine in 70% IPA sterile solution.
• DMD85006 is now subject to Protect Demand Management:
• MRB306 and MRB303 remain subject to Protect Demand Management.
• MRB306, MRB303, and DMD85006 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Five product codes remain affected in total.
• DMD85006 will not be available from all depots immediately; however, stock will be delivered into the network from 23 July 2026.
• DMD85006 will be supplied as the direct alternative to MRB303 as stock of MRB303 is depleted.
• Once MRB303 has been depleted from all depots, DMD85006 will be the replacement product until MRB303 is back in stock.
• Customers ordering DMD85006 from a depot that does not yet have stock available will receive MRB303 instead.
• NHS Supply Chain will be receiving stock of DMD85007 from 3 August 2026.
• One product code is now suspended and unavailable to order:
  • DMD85004 – 1.75ml swab stick 2% chlorhexidine in 70% IPA sterile solution.
• DMD85007 – 1.75ml swab stick 2% Chlorhexidine in 70% IPA is the US stock code for DMD85004.
• Further details will be provided once stock of DMD85004 is available to order.
• Becton Dickinson UK Ltd has confirmed that they will be price matching three alternative products for DMK000 – Skin Disinfectant Medicinal Product – 1ml sterile applicator 2% chlorhexidine gluconate in 70% IPA clear solution:
  • MRB306, MRB494 and MRB303.
• The price matching exercise will be conducted through rebates directly with Becton Dickinson UK Ltd.
• Customers are advised to contact the supplier by emailing UKI@bd.com or by telephone: 0800 917 8776 (option 2) during opening hours Monday to Friday, 08:30pm – 17:00pm.
• DMK000 remains suspended and unavailable to order.
• MRB306 and MRB303 remain subject to Protect Demand Management.
• MRB306, MRB303, and DMD85006 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Five product codes remain affected in total.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and for a full list of codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption.
• We will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 31 October 2026.

• The supply issue with Chloraprep products from Becton Dickinson UK Ltd is continuing.
• DMK000 remains suspended and unavailable to order.
• MRB306 and MRB303 remains subject to Protect Demand Management.
• MRB306 and MRB303 remains available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS However, some of these products may also be subject to intermittent supply.
• DMK000 and MRB303 are also affected products on Field Safety Notice ICN 3355. See our Useful Links section to view the details for that ICN.
• Three product codes remain affected in total.
• Additional alternatives have been sourced, and the product listing has been updated.
• See our Downloads ▼ section for a full list of product codes subject to Protect Demand Management and to access the product listing for further information on the affected product codes and potential alternatives.
• The supply issue is still anticipated to be resolved by 31 October 2026.

Change:

• The supplier Becton Dickinson UK Ltd has informed us of a supply issue with its Chloraprep products.
• There are three product codes affected:
  • DMK000 – Skin Disinfectant Medicinal Product 1ml sterile applicator 2% chlorhexidine gluconate in 70% IPA clear solution
  • MRB306 – Skin Disinfectant Medicinal Product 3ml sterile applicator 2% chlorhexidine gluconate in 70% IPA clear solution
  • MRB303 – Skin Disinfectant Medicinal Product 1.5ml sterile applicator 2% chlorhexidine gluconate in 70% IPA clear solution.
• This supply issue is due to a temporary pause in production to update the production line.
• Customers are advised to transition to clinically appropriate alternative BD ChloraPrep™ products during this period, subject to local policy and clinical suitability.
• Due to this ongoing supply issue, MRB306 and MRB303 are now being threshold managed as they are subject to Protect Demand Management.

Impact:          

• DMK000 is currently suspended and unavailable to order.
• MRB306 and MRB303 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• DMK000 and MRB303 are also affected products on Field Safety Notice ICN 3355. See our Useful Links section to view the details for that ICN.
• Potential indirect alternative products are available to order through our online catalogue. However, some of these products may also be subject to intermittent supply.
• See our Downloads ▼ section for a full list of product codes subject to Protect Demand Management and to access the product listing for further information on the affected product codes and potential alternatives.
• MRB303 and MRB306 are anticipated to be removed from Protect Demand Management by 31 July 2026.
• The supply issue is anticipated to be resolved by 31 October 2026.

Next Steps:

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternatives and the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier. We will continue to monitor the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.